New York—March 28, 2012
A leading Brazilian managed healthcare provider, Amil Par, will welcome educational partner and orthopedic powerhouse Hospital for Special Surgery as they move toward the opening of its new orthopedic center, Hospitalys, in Rio de Janeiro.
Hospitalys is on schedule for a spring debut of its initial phase. Leaders of both Amil Par and Hospital for Special Surgery will mark the occasion with an educational event and inaugural ceremony March 28. Visiting Rio to participate will be Orthopedic Surgeon-Scientist Scott A. Rodeo, M.D., and Laura Robbins, DSW, senior vice president for education and academic affairs and an associate scientist in the research division at Hospital for Special Surgery.
Dr. Rodeo, co-chief of the Sports Medicine Service at Hospital for Special Surgery, will highlight the program with a keynote lecture on “The Future of Orthopaedics.” He will address the future impact of research advances now in the laboratory such as stem cells and other emerging biologic approaches and their healing potential for regenerative therapies in elite/Olympic level athletes as well as other orthopedic injuries.
“Hospital for Special Surgery, a world leader in orthopedics, is the ideal partner for this initiative,” said Casio Zandona, CEO/RJ for Amil Par., “as they have the insight and depth of experience in general orthopedics as well as sports medicine that result in best outcomes for our patients.”
Hospitalys will specialize in spine disorders, joint replacement and sports medicine, orthopedic areas for which Hospital for Special Surgery is renowned.
As part of the educational portion of the program, Dr. Robbins will speak on “Hospital for Special Surgery: A Value-Based Model of Excellence in Healthcare Delivery,” tracing the hospital’s development from its origins to its world-class reputation today.
“We are very pleased to be collaborating with Hospitalys in Brazil and to be sharing our clinical, education and research expertise,“ said Hospital for Special Surgery President and CEO Louis A. Shapiro. “This global collaboration reflects both of our Institutions’ dedication to high quality patient care, academic excellence and cutting-edge research in orthopedics.”
HSS orthopedists and sports medicine specialists, including Dr. Rodeo, served on the U.S. Olympic Committee medical staff team that covered the Beijing Games in 2008 and the Athens Games in 2004. They look forward to similar roles in the 2012 and 2016 Games, noted Dr. Rodeo.
Among the future initiatives under consideration for this ongoing relationship, explained Dr. Robbins, may be a post-Olympic international sports medicine symposium this summer in Rio, the host city of the 2016 Games.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.